Larson Financial Group
ONCY icon

Larson Financial Group’s Oncolytics Biotech ONCY Stock Holding History

Larson Financial Group’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$112K Buy
168,323
+163,323
+3,266% +$133K ﹤0.01% 1185
2026
Q2 		$4.75K Hold
5,000
– – ﹤0.01% 2798
2026
Q1 		$4.24K Buy
+5,000
New +$4.97K ﹤0.01% 2674

Other funds holding ONCY

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 22.25% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Doliver Advisors
Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Badgley Phelps Wealth Managers
Badgley Phelps Wealth Managers Seattle, Washington $5.8B AUM 25.34% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return

Larson Financial Group's ONCY Position: Q3 2026 in Review

Larson Financial Group increased its Oncolytics Biotech (ONCY) stake by 3,266% in Q3 2026, buying an estimated $133K and bringing the position to 168,323 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1185.

Larson Financial Group first reported a position in ONCY in Q1 2026 and has held it in 3 quarters since. 33 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

  • Larson Financial Group held 168,323 shares of Oncolytics Biotech worth $112K as of Q3 2026.
  • Larson Financial Group bought 163,323 Oncolytics Biotech shares in Q3 2026, an estimated $133K.
  • Oncolytics Biotech made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1185 holding.
  • Larson Financial Group first reported a position in Oncolytics Biotech in Q1 2026 and has held it in 3 quarters since.
  • 33 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.